AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Debt History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Debt | ₹7,942 Cr | ₹6,315 Cr | ₹4,862 Cr | ₹2,373 Cr | ₹4,972 Cr |
What is the latest Total Debt ratio of AUROBINDO PHARMA ?
Year | Total Debt |
---|---|
Mar2025 | ₹7,942 Cr |
Mar2024 | ₹6,315 Cr |
Mar2023 | ₹4,862 Cr |
Mar2022 | ₹2,373 Cr |
Mar2021 | ₹4,972 Cr |
How is Total Debt of AUROBINDO PHARMA Trending?
Years | Total Debt | % Change | |
---|---|---|---|
Mar2025 | ₹7,942 Cr | 25.75 | |
Mar2024 | ₹6,315 Cr | 29.90 | |
Mar2023 | ₹4,862 Cr | 104.89 | |
Mar2022 | ₹2,373 Cr | -52.28 | |
Mar2021 | ₹4,972 Cr | - |
Compare Total Debt of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹60,115.7 Cr | 0.6% | -4.1% | -35.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹378,999.0 Cr | -0.4% | -3% | -14.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,635.0 Cr | 0.6% | -3.1% | 20.2% | Stock Analytics | |
CIPLA | ₹127,544.0 Cr | 0% | 5.2% | -5.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,050.0 Cr | 0.8% | -1.9% | 2.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,373.0 Cr | 0.1% | 3.5% | -10.6% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | 0.6% |
-4.1% |
-35.2% |
SENSEX | -0.3% |
-0.8% |
-1.9% |
You may also like the below Video Courses